These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The oncogenic ErbB-2/ErbB-3 heterodimer is a surrogate receptor of the epidermal growth factor and betacellulin. Pinkas-Kramarski R; Lenferink AE; Bacus SS; Lyass L; van de Poll ML; Klapper LN; Tzahar E; Sela M; van Zoelen EJ; Yarden Y Oncogene; 1998 Mar; 16(10):1249-58. PubMed ID: 9546426 [TBL] [Abstract][Full Text] [Related]
4. Self-phosphorylation of epidermal growth factor receptor is an intermolecular reaction. Sherrill JM Biochemistry; 1997 Oct; 36(42):12890-6. PubMed ID: 9335547 [TBL] [Abstract][Full Text] [Related]
5. Identification of EGF receptor C-terminal sequences 1005-1017 and di-leucine motif 1010LL1011 as essential in EGF receptor endocytosis. Wang Q; Zhu F; Wang Z Exp Cell Res; 2007 Sep; 313(15):3349-63. PubMed ID: 17643422 [TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells. O-charoenrat P; Modjtahedi H; Rhys-Evans P; Court WJ; Box GM; Eccles SA Cancer Res; 2000 Feb; 60(4):1121-8. PubMed ID: 10706134 [TBL] [Abstract][Full Text] [Related]
7. Ligand-independent dimer formation of epidermal growth factor receptor (EGFR) is a step separable from ligand-induced EGFR signaling. Yu X; Sharma KD; Takahashi T; Iwamoto R; Mekada E Mol Biol Cell; 2002 Jul; 13(7):2547-57. PubMed ID: 12134089 [TBL] [Abstract][Full Text] [Related]
9. Induction of heparin-binding EGF-like growth factor and activation of EGF receptor in imatinib mesylate-treated squamous carcinoma cells. Johnson FM; Saigal B; Donato NJ J Cell Physiol; 2005 Nov; 205(2):218-27. PubMed ID: 15887238 [TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor mutant with wild-type affinity for both ErbB1 and ErbB3. Wingens M; Jacobs-Oomen S; van der Woning SP; Stortelers C; van Zoelen EJ Biochemistry; 2006 Apr; 45(14):4703-10. PubMed ID: 16584205 [TBL] [Abstract][Full Text] [Related]
12. Heparin-binding epidermal growth factor-like growth factor isoforms and epidermal growth factor receptor/ErbB1 expression in bladder cancer and their relation to clinical outcome. Kramer C; Klasmeyer K; Bojar H; Schulz WA; Ackermann R; Grimm MO Cancer; 2007 May; 109(10):2016-24. PubMed ID: 17394193 [TBL] [Abstract][Full Text] [Related]
13. Activation of epidermal growth factor receptor during corneal epithelial migration. Zieske JD; Takahashi H; Hutcheon AE; Dalbone AC Invest Ophthalmol Vis Sci; 2000 May; 41(6):1346-55. PubMed ID: 10798649 [TBL] [Abstract][Full Text] [Related]
14. Heterogeneities in EGF receptor density at the cell surface can lead to concave up scatchard plot of EGF binding. Mayawala K; Vlachos DG; Edwards JS FEBS Lett; 2005 Jun; 579(14):3043-7. PubMed ID: 15896781 [TBL] [Abstract][Full Text] [Related]
15. The bioactivity and receptor affinity of recombinant tagged EGF designed for tissue engineering applications is defined by the nature and position of the tags. Boucher C; St-Laurent G; Loignon M; Jolicoeur M; De Crescenzo G; Durocher Y Tissue Eng Part A; 2008 Dec; 14(12):2069-77. PubMed ID: 18652537 [TBL] [Abstract][Full Text] [Related]
16. Persistence of dimerization and enzymatic activity of epidermal growth factor receptor in the absence of epidermal growth factor. Tanner KG Biochemistry; 1997 Dec; 36(48):14889-96. PubMed ID: 9398212 [TBL] [Abstract][Full Text] [Related]
17. Activation mechanism of solubilized epidermal growth factor receptor tyrosine kinase. Ge G; Wu J; Wang Y; Lin Q Biochem Biophys Res Commun; 2002 Jan; 290(3):914-20. PubMed ID: 11798160 [TBL] [Abstract][Full Text] [Related]
18. Human corneal epithelial cell proliferation by epiregulin and its cross-induction by other EGF family members. Morita S; Shirakata Y; Shiraishi A; Kadota Y; Hashimoto K; Higashiyama S; Ohashi Y Mol Vis; 2007 Nov; 13():2119-28. PubMed ID: 18079685 [TBL] [Abstract][Full Text] [Related]
19. A subclass of HER1 ligands are prognostic markers for survival in bladder cancer patients. Thøgersen VB; Sørensen BS; Poulsen SS; Orntoft TF; Wolf H; Nexo E Cancer Res; 2001 Aug; 61(16):6227-33. PubMed ID: 11507076 [TBL] [Abstract][Full Text] [Related]
20. The chemical synthesis and binding affinity to the EGF receptor of the EGF-like domain of heparin-binding EGF-like growth factor (HB-EGF). Shin SY; Yokoyama T; Takenouchi T; Munekata E J Pept Sci; 2003 Apr; 9(4):244-50. PubMed ID: 12725245 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]